Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years

Cancer

Volumn 120, Issue 10, 2014, Pages 1548-1556

  Kawai, Masaaki ^a   Malone, Kathleen E ^a   Tang, Mei Tzu C ^a   Li, Christopher I ^a  

^a USA   (United States)

Author keywords

body mass index; breast cancer; estrogen receptor; height; premenopausal; triple negative

Indexed keywords

EPIDERMAL GROWTH FACTOR; HUMAN EPIDERMAL GROWTH FACTOR 2; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BREAST CANCER; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HUMAN; HUMAN EPIDERMAL GROWTH FACTOR 2 POSITIVE BREAST CANCER; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NULLIPARA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR INVASION; WEIGHT CHANGE;

BODY MASS INDEX; BREAST CANCER; ESTROGEN RECEPTOR; HEIGHT; PREMENOPAUSAL; TRIPLE-NEGATIVE;

ADULT; BODY HEIGHT; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; LIFE STYLE; PARITY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; WASHINGTON;

EID: 84899930310     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28601     Document Type: Article

References (36)

1. American Institute for Cancer Research/World Cancer Research Fund. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective: A Project of World Cancer Research Fund International. Washington, DC: American Institute for Cancer Research; 2007.
2. Kabat GC, Heo M, Kamensky V, Miller AB, Rohan TE,. Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer. 2013; 132: 1125-1132.
3. Trentham-Dietz A, Newcomb PA, Storer BE, et al. Body size and risk of breast cancer. Am J Epidemiol. 1997; 145: 1011-1019.
4. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997; 278: 1407-1411.
5. Lahmann PH, Schulz M, Hoffmann K, et al. Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer. 2005; 93: 582-589.
6. Suzuki R, Iwasaki M, Inoue M, et al. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status-the Japan public health center-based prospective study. Int J Cancer. 2011; 129: 1214-1224.
7. Suzuki S, Kojima M, Tokudome S, et al. Obesity/weight gain and breast cancer risk: findings from the Japan collaborative cohort study for the evaluation of cancer risk. J Epidemiol. 2013; 23: 139-145.
8. Han D, Nie J, Bonner MR, et al. Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study. Int J Cancer. 2006; 119: 2931-2937.
9. Kawai M, Kakugawa Y, Nishino Y, Hamanaka Y, Ohuchi N, Minami Y,. Anthropometric factors, physical activity, and breast cancer risk in relation to hormone receptor and menopausal status in Japanese women: a case-control study. Cancer Causes Control. 2013; 24: 1033-1044.
10. Bao PP, Shu XO, Gao YT, et al. Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the Shanghai breast cancer study. Am J Epidemiol. 2011; 174: 661-671.
11. Ma H, Bernstein L, Ross RK, Ursin G,. Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison [serial online]. Breast Cancer Res. 2006; 8: R39.
12. McCredie MR, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL,. Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status. Br J Cancer. 2003; 89: 1661-1663.
13. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG,. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000; 151: 703-714.
14. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L,. Body size, physical activity, and breast cancer hormone receptor status: results from 2 case-control studies. Cancer Epidemiol Biomarkers Prev. 2000; 9: 681-687.
15. John EM, Sangaramoorthy M, Phipps AI, Koo J, Horn-Ross PL,. Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study. Am J Epidemiol. 2011; 173: 201-216.
16. Fagherazzi G, Chabbert-Buffet N, Fabre A, et al. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer. Int J Obes (Lond). 2012; 36: 431-439.
17. Britton JA, Gammon MD, Schoenberg JB, et al. Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age. Am J Epidemiol. 2002; 156: 507-516.
18. Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S,. Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev. 2003; 12: 1053-1060.
19. Ritte R, Lukanova A, Berrino F, et al. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study [serial online]. Breast Cancer Res. 2012; 14: R76.
20. Sueta A, Ito H, Islam T, et al. Differential impact of body mass index and its change on the risk of breast cancer by molecular subtype: a case-control study in Japanese women [serial online]. Springerplus. 2012; 1: 39.
21. Millikan RC, Newman B, Tse CK, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008; 109: 123-139.
22. Gaudet MM, Press MF, Haile RW, et al. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat. 2011; 130: 587-597.
23. Yang XR, Sherman ME, Rimm DL, et al. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev. 2007; 16: 439-443.
24. Phipps AI, Buist DS, Malone KE, et al. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol. 2012; 22: 340-348.
25. Dolle JM, Daling JR, White E, et al. Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1157-1166.
26. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295: 2492-2502.
27. Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A. 2003; 100: 10393-10398.
28. Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE,. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. Breast Cancer Res Treat. 2013; 137: 579-587.
29. Kawai M, Malone KE, Tang MT, Li CI,. Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years. Cancer. 2014; doi: 10.1002/cncr.28402.
30. Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE,. Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age. Cancer Res. 2012; 72: 2028-2035.
31. Waksberg J,. Sampling methods for random digit dialing. J Am Stat Assoc. 1978; 73: 40-46.
32. Sherman BM, Korenman SG,. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase. J Clin Endocrinol Metab. 1974; 39: 145-149.
33. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ,. Comparative study of human and rat mammary tumorigenesis. Lab Invest. 1990; 62: 244-278.
34. Juul A, Bang P, Hertel NT, et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab. 1994; 78: 744-752.
35. Regensteiner JG, Mayer EJ, Shetterly SM, et al. Relationship between habitual physical activity and insulin levels among nondiabetic men and women. San Luis Valley Diabetes Study. Diabetes Care. 1991; 14: 1066-1074.
36. Rothman KJ, Greenland S, Lash TL,. Modern Epidemiology. 3rd ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.